Janux Therapeutics (JANX) Asset Utilization Ratio (2021 - 2025)
Historic Asset Utilization Ratio for Janux Therapeutics (JANX) over the last 5 years, with Q3 2025 value amounting to 0.01.
- Janux Therapeutics' Asset Utilization Ratio fell 4834.75% to 0.01 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.01, marking a year-over-year decrease of 4834.75%. This contributed to the annual value of 0.01 for FY2024, which is 3237.37% down from last year.
- According to the latest figures from Q3 2025, Janux Therapeutics' Asset Utilization Ratio is 0.01, which was down 4834.75% from 0.0 recorded in Q2 2025.
- In the past 5 years, Janux Therapeutics' Asset Utilization Ratio ranged from a high of 0.03 in Q1 2023 and a low of 0.0 during Q2 2025
- Over the past 5 years, Janux Therapeutics' median Asset Utilization Ratio value was 0.02 (recorded in 2022), while the average stood at 0.02.
- Per our database at Business Quant, Janux Therapeutics' Asset Utilization Ratio surged by 27817.06% in 2022 and then tumbled by 9807.68% in 2025.
- Over the past 5 years, Janux Therapeutics' Asset Utilization Ratio (Quarter) stood at 0.01 in 2021, then soared by 146.76% to 0.02 in 2022, then fell by 9.51% to 0.02 in 2023, then tumbled by 42.78% to 0.01 in 2024, then dropped by 19.35% to 0.01 in 2025.
- Its last three reported values are 0.01 in Q3 2025, 0.0 for Q2 2025, and 0.01 during Q1 2025.